vardenafil (Klaria Pharma)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namevardenafil (Klaria Pharma)
Drug Alias Namevardenafil (Karessa)vardenafilK-03
ClassificationSmall molecules
Mechanisms of ActionPhosphodiesterase 5A inhibitors
TargetsPhosphodiesterase 5A
Therapy Area/IndicationsErectile Dysfunction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKaressa Pharma Holding AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKaressa Pharma Holding AB
Active IndicationsN/A
Inactive IndicationsErectile Dysfunction

Other Information

ATC CodeN/A
Related LinksN/A